An Ascending Dose Tolerability Study and Pharmacokinetic Assessment in Healthy Male and Female Volunteers After Single & Multiple Oral Administration of DF2755A
Latest Information Update: 03 May 2024
At a glance
- Drugs DF 2755A (Primary)
- Indications Inflammatory pain; Postoperative pain
- Focus Adverse reactions
- Sponsors Dompe Farmaceutici
Most Recent Events
- 24 Mar 2021 New trial record